IPGP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
IPG Photonics Corp (IPGP) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial growth in the latest quarter and has positive developments in its business, the recent sharp price decline (-6.76% regular market change) and mixed analyst ratings suggest caution. The technical indicators are neutral to slightly bearish, and there are no strong proprietary trading signals to support an immediate buy decision. It is better to monitor the stock for a more favorable entry point.
The stock's MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 49.413, showing no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below its pivot level of 136.415, with key support at 121.154 and resistance at 151.676. Overall, the technical signals are mixed, leaning slightly bearish.
The company secured a $10 million order with delivery expected over multiple quarters, indicating strong demand.
Financial performance in Q4 2025 showed significant YoY growth in revenue (+17.13%), net income (+69.80%), and EPS (+72.22%).
A German court ruling found IPG's adjustable mode beam lasers infringe on a Trumpf patent, which could lead to legal and operational challenges.
Gross margin dropped to 36.1%, down -6.36% YoY, indicating potential cost pressures.
The stock experienced a sharp decline of -6.76% in regular market trading, which could signal investor concerns.
In Q4 2025, IPG Photonics reported strong financial growth: Revenue increased by 17.13% YoY to $274.47 million, net income rose by 69.80% YoY to $13.27 million, and EPS grew by 72.22% YoY to 0.31. However, gross margin declined to 36.1%, down -6.36% YoY, which may indicate rising costs or pricing pressures.
Analyst sentiment is mixed. Stifel raised the price target to $165 and maintained a Buy rating, citing strong demand and diversification into high-margin markets. Raymond James raised the price target to $180 but downgraded the stock to Outperform from Strong Buy due to concerns about valuation after a sharp rally. Roth Capital raised the price target to $110 and maintained a Buy rating, citing stabilization in manufacturing and growth in new product areas.
